These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Macular corneal dystrophy in Saudi Arabia: a study of 56 cases and recognition of a new immunophenotype. Klintworth GK; Oshima E; al-Rajhi A; al-Saif A; Thonar EJ; Karcioglu ZA Am J Ophthalmol; 1997 Jul; 124(1):9-18. PubMed ID: 9222226 [TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical evidence of heterogeneity in macular corneal dystrophy. Yang CJ; SundarRaj N; Thonar EJ; Klintworth GK Am J Ophthalmol; 1988 Jul; 106(1):65-71. PubMed ID: 3293458 [TBL] [Abstract][Full Text] [Related]
4. Absence of normal keratan sulfate in the blood of patients with macular corneal dystrophy. Thonar EJ; Meyer RF; Dennis RF; Lenz ME; Maldonado B; Hassell JR; Hewitt AT; Stark WJ; Stock EL; Kuettner KE Am J Ophthalmol; 1986 Nov; 102(5):561-9. PubMed ID: 2946233 [TBL] [Abstract][Full Text] [Related]
5. Macular corneal dystrophy. Lack of keratan sulfate in serum and cornea. Klintworth GK; Meyer R; Dennis R; Hewitt AT; Stock EL; Lenz ME; Hassell JR; Stark WJ; Kuettner KE; Thonar EJ Ophthalmic Paediatr Genet; 1986 Dec; 7(3):139-43. PubMed ID: 2951638 [TBL] [Abstract][Full Text] [Related]
6. [Immunophenotype classification of macular corneal dystrophy: first case report of immunophenotype I A outside of Saudi Arabia. A clinical histopathological correlation with immunohistochemistry and electron microscopy]. Cursiefen C; Hofmann-Rummelt C; Schlötzer-Schrehardt U; Fischer DC; Küchle M Klin Monbl Augenheilkd; 2000 Aug; 217(2):118-26. PubMed ID: 11022667 [TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical classification of primary and recurrent macular corneal dystrophy in Germany: subclassification of immunophenotype I A using a novel keratan sulfate antibody. Cursiefen C; Hofmann-Rummelt C; Schlötzer-Schrehardt U; Fischer DC; Haubeck HD; Küchle M; Naumann GO Exp Eye Res; 2001 Nov; 73(5):593-600. PubMed ID: 11747360 [TBL] [Abstract][Full Text] [Related]
9. Abnormalities of proteoglycans and glycoproteins synthesized by corneal organ cultures derived from patients with macular corneal dystrophy. Klintworth GK; Smith CF Lab Invest; 1983 May; 48(5):603-12. PubMed ID: 6601743 [TBL] [Abstract][Full Text] [Related]
10. Macular corneal dystrophy: failure to synthesize a mature keratan sulfate proteoglycan. Hassell JR; Newsome DA; Krachmer JH; Rodrigues MM Proc Natl Acad Sci U S A; 1980 Jun; 77(6):3705-9. PubMed ID: 6447876 [TBL] [Abstract][Full Text] [Related]
11. Macular dystrophy of the cornea. A systemic disorder of keratan sulfate metabolism. Edward DP; Thonar EJ; Srinivasan M; Yue BJ; Tso MO Ophthalmology; 1990 Sep; 97(9):1194-200. PubMed ID: 2234853 [TBL] [Abstract][Full Text] [Related]
12. Macular corneal dystrophy. Studies of sulfated glycosaminoglycans in corneal explant and confluent stromal cell cultures. Klintworth GK; Smith CF Am J Pathol; 1977 Oct; 89(1):167-82. PubMed ID: 143892 [TBL] [Abstract][Full Text] [Related]
13. Keratan sulphate in the trabecular meshwork and cornea. Davies Y; Fullwood NJ; Marcyniuk B; Bonshek R; Tullo A; Nieduszynski IA Curr Eye Res; 1997 Jul; 16(7):677-86. PubMed ID: 9222085 [TBL] [Abstract][Full Text] [Related]
14. Macular corneal dystrophy: reduction in both corneal thickness and collagen interfibrillar spacing. Quantock AJ; Meek KM; Ridgway AE; Bron AJ; Thonar EJ Curr Eye Res; 1990 Apr; 9(4):393-8. PubMed ID: 2340750 [TBL] [Abstract][Full Text] [Related]
15. Macular corneal dystrophy in Iceland. A clinical, genealogic, and immunohistochemical study of 28 patients. Jonasson F; Oshima E; Thonar EJ; Smith CF; Johannsson JH; Klintworth GK Ophthalmology; 1996 Jul; 103(7):1111-7. PubMed ID: 8684802 [TBL] [Abstract][Full Text] [Related]
16. Measurement of activities of human serum sulfotransferases which transfer sulfate to the galactose residues of keratan sulfate and to the nonreducing end N-acetylglucosamine residues of N-acetyllactosamine trisaccharide: comparison between normal controls and patients with macular corneal dystrophy. Hasegawa N; Torii T; Nagaoka I; Nakayasu K; Miyajima H; Habuchi O J Biochem; 1999 Feb; 125(2):245-52. PubMed ID: 9990120 [TBL] [Abstract][Full Text] [Related]
17. Ultrastructural localization of sulfated and unsulfated keratan sulfate in normal and macular corneal dystrophy type I. Lewis D; Davies Y; Nieduszynski IA; Lawrence F; Quantock AJ; Bonshek R; Fullwood NJ Glycobiology; 2000 Mar; 10(3):305-12. PubMed ID: 10704529 [TBL] [Abstract][Full Text] [Related]
18. Recurrent macular corneal dystrophy type II 49 years after penetrating keratoplasty. Küchle M; Cursiefen C; Fischer DC; Schlötzer-Schrehardt U; Naumann GO Arch Ophthalmol; 1999 Apr; 117(4):528-31. PubMed ID: 10206585 [TBL] [Abstract][Full Text] [Related]
19. Macular corneal dystrophy: the macromolecular structure of the stroma observed using electron microscopy and synchrotron X-ray diffraction. Meek KM; Quantock AJ; Elliott GF; Ridgway AE; Tullo AB; Bron AJ; Thonar EJ Exp Eye Res; 1989 Dec; 49(6):941-58. PubMed ID: 2515072 [TBL] [Abstract][Full Text] [Related]
20. Serum sulfotransferase levels in patients with macular corneal dystrophy type I. Hassell JR; Klintworth GK Arch Ophthalmol; 1997 Nov; 115(11):1419-21. PubMed ID: 9366673 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]